Effect of topical treatments of psoriasis with ointment Fluocinolon 0.125% and lotion Betamethasone 0.05% on the level of IL-17 in patients with psoriasis

Effect of topical treatments of psoriasis with ointment Fluocinolon 0.125% and lotion Betamethasone 0.05% on the level of IL-17 in patients with psoriasis: a before-after clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201606289014N104

Enrollment

Registered

2016-07-05

Start date

2016-05-14

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis. Psoriasis

Interventions

Intervention 1: Ointment Fluocinolon 0.125% for lesions of trunk and limbs and lotion Betamethasone 0.05% for scalp lesions very night for one month. Intervention 2: there is no comparison group. The

Treatment - Drugs

Ointment Fluocinolon 0.125% for lesions of trunk and limbs and lotion Betamethasone 0.05% for scalp lesions very night for one month

there is no comparison group. The intervention group will be compared before and after intervention.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Having psoriatic lesions. Exclusion criteria: (a) pregnancy or breastfeeding; (b) using local or systemic corticosteroid during the past 3 months; (c) history of autoimmune or inflammatory disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Measuring the level of IL-17. Timepoint: before treatment and 4 weeks after treatment. Method of measurement: using laboratory test.	—

Secondary

Measure	Time frame
Nothing. Timepoint: Nothing. Method of measurement: Nothing.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Fariba Shadfar

Farshchian Hospital

faribashadfar03@gmail.com+81 38274184

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026